BABA
Alibaba Group Holding Limited
BABA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
TRS
TriMas Corporation
TRS has the edge over BABA overall, supported by stronger valuation and stronger modeled upside.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
TRS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| Under pressure | |
| Strong |
TRS's profitability and balance sheet are currently healthy, but its revenue and cash flow are under pressure.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
TRS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 1.6x | $37.62 | — |
| Cheap | 12x | $286 | +661% |
| Forward | 19x | $37.62 | — |
| Fair | 21x | $504 | +1238% |
| Expensive | 33x | $795 | +2012% |
Historical ranges are pointers, not guarantees.
TRS has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over TRS on the outlook, with more favorable revenue expectations.
TRS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect TRS's earnings to grow and its profitability to improve, with its revenue holding steady.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA's earnings per share have fallen from their peak: $4.42 over the past year, against $9.27 in mid-2025. Its recent earnings include one-off gains.
TRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | -92% |
| Q2 2026 | $24.03 | +2541% |
| Q1 2026 | $24.07 | +3026% |
| Q4 2025 | $2.97 | +403% |
| Q3 2025 | $1.08 | +69% |
| Q2 2025 | $0.91 | -7.1% |
| Q1 2025 | $0.77 | -21% |
| Q4 2024 | $0.59 | -39% |
| Q3 2024 | $0.64 | -48% |
TRS has the edge over BABA on earnings, with stronger typical year-over-year growth.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over TRS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over TRS on profitability, with a higher operating margin.
TRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $174.6M | -36% |
| Q1 2026 | $168.3M | -30% |
| Q4 2025 | $155.5M | -32% |
| Q3 2025 | $269.3M | +17% |
| Q2 2025 | $274.8M | +14% |
| Q1 2025 | $241.7M | +6.4% |
| Q4 2024 | $228.1M | +8.8% |
| Q3 2024 | $229.4M | -2.5% |
TRS's revenue has slid since its 2025 peak: $175M last quarter, down 36% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 6.2% | -3.6 points |
| Q1 2026 | 4.1% | -4.9 points |
| Q4 2025 | -16% | -19 points |
| Q3 2025 | 6.2% | +2.6 points |
| Q2 2025 | 9.9% | +2.4 points |
| Q1 2025 | 9% | +3.5 points |
| Q4 2024 | 3.8% | -1.8 points |
| Q3 2024 | 3.6% | -6.5 points |
TRS's operating margin was 6.2% last quarter, down 3.6 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
TRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$45M | -440% |
| Q1 2026 | -$24.6M | -$20.9M |
| Q4 2025 | $36.8M | +204% |
| Q3 2025 | $22.8M | +125% |
| Q2 2025 | $13.2M | +76% |
| Q1 2025 | -$3.8M | +$13.2M |
| Q4 2024 | $12.1M | +6.7% |
| Q3 2024 | $10.2M | -52% |
TRS has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
TRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.2% | -1.2M shares |
| 1 year | -12% | -4.7M shares |
| 3 years | -13% | -5.4M shares |
| 5 years | -16% | -7.1M shares |
| Available history | -20% | -9.2M shares |
TRS has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $18.9M |
| Q1 2026 | $54.5M |
| Q4 2025 | $101.1M |
| Q3 2025 | — |
| Q2 2025 | $1.8M |
| Q1 2025 | $460,000 |
| Q4 2024 | — |
| Q3 2024 | $2.4M |
TRS spent $175M buying back its own shares over the past year, more than ten times what it spent the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
TRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -14.4x | Net Cash |
| Q1 2026 | -11.5x | Net Cash |
| Q4 2025 | 4.5x | High |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 3.0x | Elevated |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | 3.4x | Elevated |
| Q3 2024 | 3.6x | Elevated |
TRS has the edge over BABA on leverage, with a lower net debt burden relative to earnings.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
TRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 27.0 | Neutral |
TRS's weekly RSI is 45 (neutral) and its Stochastic is 27 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
TRS PE vs Consumer Cyclical Sector
| Metric | TRS | Sector median | Relative |
|---|---|---|---|
| PE | 1.6x | 18x | 91% below |
| PE % | 0 | 47 | 47 pts below |
TRS has the edge over BABA on valuation relative to its sector.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
TRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.6 | 2.6% below |
| 20 week MA | $39.4 | 4.4% below |
| 50 week MA | $38.2 | 1.5% below |
| 100 week MA | $33.6 | 12% above |
| 200 week MA | $29.9 | 26% above |
TRS has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
TRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.2 | $32.0 | +2.6% |
| 2021 | $32.0 | $34.8 | +8.5% |
| 2022 | $34.8 | $27.8 | -20% |
| 2023 | $27.8 | $25.3 | -8.7% |
| 2024 | $25.3 | $24.6 | -3% |
| 2025 | $24.6 | $36.1 | +47% |
| 2026 YTD | $36.1 | $37.6 | +4.1% |
TRS has the edge over BABA on returns for 2026, with the stronger performance.